Genome-wide functions of PML–RARα in acute promyelocytic leukaemia

被引：0
|
作者：
S Saeed
C Logie
H G Stunnenberg
J H A Martens
机构：
[1] Faculty of Science,Department of Molecular Biology
[2] Nijmegen Centre for Molecular Life Sciences,undefined
[3] Radboud University,undefined
来源：
British Journal of Cancer | 2011年 / 104卷
关键词：
PML-RAR; RXR; PU.1 (SPI1); epigenome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
PML—RAR (retinoic acid receptor)α is the hallmark protein of acute promyelocytic leukaemia, a highly malignant subtype of acute myeloid leukaemia that accounts for approximately 10% of all AML cases. Recently, several studies have been set out to obtain a comprehensive genome-wide view of the molecular actions of this chimeric protein. In this review, we highlight the new insights that arose from these studies, in particular focussing on newly identified PML–RARα target genes, its interplay with RXR and deregulation of epigenetic modifications.
引用
收藏
页码：554 / 558
页数：4
相关论文
共 50 条
  • [41] EXPRESSION PATTERN OF THE RAR-ALPHA-PML FUSION GENE IN ACUTE PROMYELOCYTIC LEUKEMIA
    ALCALAY, M
    ZANGRILLI, D
    FAGIOLI, M
    PANDOLFI, PP
    MENCARELLI, A
    LOCOCO, F
    BIONDI, A
    GRIGNANI, F
    PELICCI, PG
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (11) : 4840 - 4844
  • [42] Molecular analysis of the PML/RAR alpha chimeric gene in pediatric acute promyelocytic leukemia
    Kane, JR
    Head, DR
    Balazs, L
    Hulshof, MG
    Motroni, TA
    Raimondi, SC
    Carroll, AJ
    Beh, FG
    Krance, RA
    Shurtleff, SA
    Downing, JR
    LEUKEMIA, 1996, 10 (08) : 1296 - 1302
  • [43] PML-RARα inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia
    Ohnishi, Kazunori
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2007, 12 (05) : 313 - 317
  • [44] Distinct leukemogenic mechanism of acute promyelocytic leukemia based on genomic structure of PML::RARα
    Minami, Mariko
    Sakoda, Teppei
    Kawano, Gentaro
    Kochi, Yu
    Sasaki, Kensuke
    Sugio, Takeshi
    Jinnouchi, Fumiaki
    Miyawaki, Kohta
    Kunisaki, Yuya
    Kato, Koji
    Miyamoto, Toshihiro
    Akashi, Koichi
    Kikushige, Yoshikane
    LEUKEMIA, 2025, : 844 - 853
  • [45] Cryptic PML-RARα positive acute promyelocytic leukemia with unusual morphology and cytogenetics
    Goyal, Manu
    Dattatreya, Palinki S.
    Goud, Irawathy
    Murthy, Sudha S.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2010, 53 (04) : 817 - 819
  • [46] THE PML/RAR-ALPHA FUSION GENE IN THE DIAGNOSIS AND MONITORING OF ACUTE PROMYELOCYTIC LEUKEMIA
    DIVERIO, D
    RICCIONI, R
    MANDELLI, F
    LOCOCO, F
    HAEMATOLOGICA, 1995, 80 (02) : 155 - 160
  • [47] Effects of the PML/RAR alpha gene product on the regulation of adhesion molecules in acute promyelocytic
    Pinto, A
    Aldinucci, D
    Gattei, V
    Juzbasic, S
    Improta, S
    Perin, V
    Rossi, FM
    Degan, M
    DeIuliis, A
    Grignani, F
    Pelicci, PG
    TISSUE ANTIGENS, 1996, 48 (4-II): : AS306 - AS306
  • [48] MiRNA transcription is regulated by the PML-RARα oncoprotein in acute promyelocytic leukemia.
    Nigten, Jeannet
    Knops, Ruth
    Nikoloski, Gorica
    de Witte, Theo M.
    van der Reijden, Bert A.
    Jansen, Joop H.
    BLOOD, 2006, 108 (11) : 129B - 129B
  • [49] TRANSLOCATION OF THE RAR-ALPHA LOCUS TO THE PML OR PLZF GENE IN ACUTE PROMYELOCYTIC LEUKEMIA
    ZELENT, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (03) : 451 - 460
  • [50] PML-RARα inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia
    Kazunori Ohnishi
    International Journal of Clinical Oncology, 2007, 12 : 313 - 317
12345